摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-chlorophenyl)pent-4-enoic acid | 51230-92-3

中文名称
——
中文别名
——
英文名称
2-(4-chlorophenyl)pent-4-enoic acid
英文别名
2-(4-Chlorophenyl)pent-4-enoicacid
2-(4-chlorophenyl)pent-4-enoic acid化学式
CAS
51230-92-3
化学式
C11H11ClO2
mdl
——
分子量
210.66
InChiKey
LLSZDJYYZJMKEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    325.7±27.0 °C(Predicted)
  • 密度:
    1.209±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-chlorophenyl)pent-4-enoic acid硫酸 作用下, 以100%的产率得到3-(4-chlorophenyl)-5-methyltetrahydrofuran-2-one
    参考文献:
    名称:
    3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring
    摘要:
    A series of racemic 3-phenyl-5-methyl-2H,5H-furan-2-ones related to a natural product, (-)incrustoporine, was synthesized, and their antifungal activity evaluated. The key structural feature, furanone ring, was closed via H2SO4-mediated cyclization of 3-phenylpent-4-enoic acids. The compounds displayed antifungal activity, especially against filamentous fungi. Expressed as the minimum inhibition concentration (MIC) in mu mol/L, the activity of the most promising derivative against Absidia corymbifera matched that of ketoconazole (31.25 mu mol/L). In terms of mu g/mL, the substance was more active (7.6 mu g/mL) than this standard antifungal drug (16.6 mu g/mL). (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00376-0
  • 作为产物:
    描述:
    对氯苯乙酸甲酯 在 lithium hydroxide 、 正丁基锂二异丙胺 作用下, 以 四氢呋喃甲醇正己烷 为溶剂, 反应 22.0h, 生成 2-(4-chlorophenyl)pent-4-enoic acid
    参考文献:
    名称:
    Synthesis and structure–antifungal activity Relationships of 3-Aryl-5-alkyl-2,5-dihydrofuran-2-ones and Their Carbanalogues: further refinement of tentative pharmacophore group
    摘要:
    Two series of 3-(substituted phenyl)-5-alkyl-2,5-dihydrofuran-2-ones related to a natural product, (-)incrustoporine, were synthesized and their in vitro antifungal activity evaluated. The compounds with halogen substituents on the phenyl ring exhibited selective antifungal activity against the filamentous strains of Absidia corymbifera and Aspergillus fumigatus. On the other hand, the influence of the lenghth of the alkyl chain at C(5) was marginal. The antifungal effect of the most active compound against the above strains was higher than that of ketoconazole, and close to that of amphotericin B. In order to verify the hypothesis about a possible relationship between the Michael-accepting ability of the compounds and their antifungal activity, a series of simple carbanalogues, 2-(substituted phenyl)cyclopent-2-enones, was prepared and subjected to antifungal activity assay as well. (C) 2003 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(03)00220-7
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY<br/>[FR] COMPOSES PRESENTANT UNE AFFINITE AVEC LE RECEPTEUR 5HT2C ET UTILISATION THERAPEUTIQUE DE CEUX-CI
    申请人:GLAXO GROUP LTD
    公开号:WO2003089409A1
    公开(公告)日:2003-10-30
    Compounds of formula (I) or a pharmaceutically acceptable salt thereof are disclosed: wherein R1 is hydrogen, hydroxy, fluoro, chloro, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, C1-6alkoxy or haloC1-6alkoxy; m is 0 when ======= is a double bond and m is 1 when ======= is a single bond; R2 is hydrogen, halogen, cyano, nitro, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, haloC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy, C1-6alkylthio, amino, mono- or di-C1-6alkylamino or an N-linked 4 to 7 membered heterocyclic group; X is -(CH2-CH2)-, -(CH=CH)-, -(CH2)3-, -C(CH3)2-, -(CH=CH-CH2)-, -(CH2-CH=CH)- or a group -(CHR5)- wherein R5 is hydrogen, halogen, hydroxy, cyano, nitro, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, haloC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy or C1-6alkylthio; R3 is halogen, cyano, C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkyloxy, C1-6alkoxy, C1-6alkylthio, hydroxy, amino, mono- or di-C1-6alkylamino, an N-linked 4 to 7 membered heterocyclic group, nitro, haloC1-6alkyl, haloC1-6alkoxy, aryl, arylC1-6alkyl, arylC1-6alkyloxy, arylC1-6alkylthio or COOR6, CONR7R8 or COR9 wherein R6, R7, R8 and R9 are independently hydrogen or C1-6alkyl; p is 0, 1 or 2 or 3; R4 is hydrogen, halogen, hydroxy, cyano, nitro, C1-6alkyl, C1-6alkanoyl, C3-7cycloalkyl, C3-7cycloalkyloxy, haloC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy, C1-6alkylthio, amino, mono- or di-C1-6alkylamino or an N-linked 4 to 7 membered heterocyclic group; Y is oxygen, sulfur, -CH2- or NR10 wherein R10 is hydrogen or C1-6alkyl; D is a single bond, -CH2-, -(CH2)2- or -CH=CH-; and Z is an optionally substituted C-linked 4 to 7 membered heterocyclic group containing at least one nitrogen, an optionally substituted N-linked 4 to 7 membered heterocyclic group, or Z is -NR11R12 where R11 and R12 are independently hydrogen or C1-6alkyl. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression and anxiety, are also disclosed.
    公式(I)的化合物或其药学上可接受的盐被披露:其中R1是氢,羟基,氟,氯,C1-6烷基,C3-7环烷基,C3-7环烷氧基,C1-6烷氧基或卤代C1-6烷氧基;当=======是双键时,m为0,当=======是单键时,m为1;R2是氢,卤素,氰基,硝基,C1-6烷基,C3-7环烷基,C3-7环烷氧基,卤代C1-6烷基,C1-6烷氧基,卤代C1-6烷氧基,C1-6烷硫基,氨基,单或双C1-6烷基氨基或N-连接的4至7成员杂环基;X是-(CH2-CH2)-,-(CH=CH)-,-(CH2)3-,-C(CH3)2-,-(CH=CH-CH2)-,-(CH2-CH=CH)-或一个基团-(CHR5)-其中R5是氢,卤素,羟基,氰基,硝基,C1-6烷基,C3-7环烷基,C3-7环烷氧基,卤代C1-6烷基,C1-6烷氧基,卤代C1-6烷氧基或C1-6烷硫基;R3是卤素,氰基,C1-6烷基,C3-7环烷基,C3-7环烷氧基,C1-6烷氧基,C1-6烷硫基,羟基,氨基,单或双C1-6烷基氨基,N-连接的4至7成员杂环基,硝基,卤代C1-6烷基,卤代C1-6烷氧基,芳基,芳基C1-6烷基,芳基C1-6烷氧基,芳基C1-6烷硫基或COOR6,CONR7R8或COR9其中R6,R7,R8和R9独立地是氢或C1-6烷基;p是0,1,2或3;R4是氢,卤素,羟基,氰基,硝基,C1-6烷基,C1-6烷酰基,C3-7环烷基,C3-7环烷氧基,卤代C1-6烷基,C1-6烷氧基,卤代C1-6烷氧基,C1-6烷硫基,氨基,单或双C1-6烷基氨基或N-连接的4至7成员杂环基;Y是氧,硫,-CH2-或NR10其中R10是氢或C1-6烷基;D是单键,-CH2-,-(CH2)2-或-CH=CH-;Z是含有至少一个氮的可选择取代的C-连接的4至7成员杂环基,可选择取代的N-连接的4至7成员杂环基,或Z是-NR11R12其中R11和R12独立地是氢或C1-6烷基。还披露了其制备方法和在治疗中的用途,特别是用于中枢神经系统疾病如抑郁症和焦虑症。
  • PhSO<sub>2</sub>SCF<sub>2</sub>H: A Shelf-Stable, Easily Scalable Reagent for Radical Difluoromethylthiolation
    作者:Dianhu Zhu、Xinxin Shao、Xin Hong、Long Lu、Qilong Shen
    DOI:10.1002/anie.201609468
    日期:2016.12.19
    A new shelf‐stable and easily scalable difluoromethylthiolating reagent S‐(difluoromethyl) benzenesulfonothioate (PhSO2SCF2H) was developed. PhSO2SCF2H is a powerful reagent for radical difluoromethylthiolation of aryl and alkyl boronic acids, decarboxylative difluoromethylthiolation of aliphatic acids, and a phenylsulfonyl‐difluoromethylthio difunctionalization of alkenes under mild reaction conditions
    开发了一种新的货架稳定且易于扩展的二氟甲基硫醇化试剂S-(二氟甲基)苯磺酸硫(PhSO 2 SCF 2 H)。PhSO 2 SCF 2 H是用于在温和的反应条件下进行芳基和烷基硼酸的自由基二氟甲硫基化,脂肪酸的脱羧二氟甲硫基化以及烯烃的苯磺酰基-二氟甲硫基二官能化的强大试剂。
  • Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure–activity relationships for substituted 2-aryl-1-[ N -(methyl)- N -(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes
    作者:Paul E Finke、Laura C Meurer、Bryan Oates、Sander G Mills、Malcolm MacCoss、Lorraine Malkowitz、Martin S Springer、Bruce L Daugherty、Sandra L Gould、Julie A DeMartino、Salvatore J Siciliano、Anthony Carella、Gwen Carver、Karen Holmes、Renee Danzeisen、Daria Hazuda、Joseph Kessler、Janet Lineberger、Michael Miller、William A Schleif、Emilio A Emini
    DOI:10.1016/s0960-894x(00)00639-9
    日期:2001.1
    (2S)-2-(3,4-Dichlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[spiro(2,3-dihydrobenzthiophene-3,4'-piperidin-1'-yl)]butane S-oxide (3) has been identified as a potent CCR5 antagonist lead structure having an IC50 = 35 nM. Herein, we describe the structure-activity relationship studies directed toward the requirement for and optimization of the C-2 phenyl fragment. The phenyl was found to be important for CCR5 antagonism and substitution was limited to small moieties at the 3-position (13 and 16. X=H, 3-F, 3-Cl, 3-Me). (C) 2001 Published by Elsevier Science Ltd.
    (2S)-2-(3,4-二氯苯基)-1-[N-(甲基)-N-(苯基亚砜)氨基]-4-[螺(2,3-二氢苯并噻吩-3,4'-哌啶-1'-基)]丁烷 S-氧化物 (3) 已被鉴定为一种具有强效 CCR5 拮抗活性的先导结构化合物,其 IC50 值为 35 nM。本文中,我们描述了针对 C-2 苯基片段的需求和优化的结构-活性关系研究。研究发现,苯基对于 CCR5 拮抗活性至关重要,取代基仅限于在 3 位引入小型基团(如 13 和 16,当 X=H、3-F、3-Cl、3-Me 时)。(C) 2001 Elsevier Science Ltd. 出版。
  • Oxidative oxygen-nucleophilic bromo-cyclization of alkenyl carbonyl compounds without organic wastes using alkali metal reagents in green solvent
    作者:Katsuhiko Moriyama、Chihiro Nishinohara、Toru Sugiue、Hideo Togo
    DOI:10.1039/c5ra19851h
    日期:——
    developed via the oxidative umpolung of bromide using alkali metal bromide and inorganic oxidant to provide the corresponding cyclization products in high yields. In particular, the use of AcOEt, the solvent of choice for green sustainable reactions, led to the high reactivities of the present reactions. This methodology is highly recommended for green sustainable chemistry because it uses stable and non-hazardous
    通过使用碱金属溴化物和无机氧化剂,通过溴化物的氧化反应,开发了烯基羧酸的溴内酯化和作为氧亲核性溴环化反应的N-烯丙基酰胺的溴环化反应,从而高收率地提供了相应的环化产物。特别地,使用AcOEt,绿色可持续反应的首选溶剂,导致了本反应的高反应性。强烈建议将此方法用于绿色可持续化学,因为它使用稳定且无害的试剂代替其他溴试剂和氧化剂,并且不会产生污染环境的有机废物。
  • Trialkylamine-Mediated Intramolecular Acylation of Akenes with Carboxylic Acid Chlorides
    作者:Jun-ichi Matsuo、Takaya Hoshikawa、Shun Sasaki、Hiroyuki Ishibashi
    DOI:10.1248/cpb.58.591
    日期:——
    Trialkylamine-mediated intramolecular cyclization of pent-4-enoyl chlorides was studied. Substitution with a tertiary alkyl group at the 2-position gave cyclopent-2-en-1-ones, while substitution with an aromatic group gave enol esters, which were formed by O-acylation of initially formed 3-chlorocyclopentanones with ketenes.
    研究了三烷基胺介导的戊-4-烯酰氯分子内环化。在 2 位用叔烷基取代可得到环戊-2-烯-1-酮,而用芳香基取代可得到烯醇酯,烯醇酯是由最初形成的 3-氯环戊酮与烯酮发生 O-酰化反应而形成的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐